Spark Therapeutics’ Luxturna is a gene therapy that treats a rare inherited retinal disease that can lead to blindness. The cost? A one-time treatment has an $850,000 price tag. The U.S. drug maker has the first gene therapy in the nation to treat the rare disease and had just been approved by the Food and … Continue reading “Spark Therapeutics Can Cure Rare Blindness For $850,000”
